Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | PARG | Q86W56 | 1/20 | 0.45 |
| ▸ | ALOX5AP | P20292 | 7/20 | 0.44 |
| ▸ | FEN1 | P39748 | 7/20 | 0.44 |
| ▸ | UQCRB | P14927 | 1/20 | 0.42 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | ACLY | P53396 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.39 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2803354 | 0.85 | NSD2 (0.58) | NSD2MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL32664392 | 0.79 | CYP1A2 (0.51) | MEN1KMT2ALMNAALOX5APFEN1 | |
| SCHEMBL13075810 | 0.78 | NSD2 (0.51) | NSD2MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL23345388 | 0.78 | NSD2 (0.51) | NSD2MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL634084 | 0.78 | NSD2 (0.51) | NSD2MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL29442141 | 0.77 | NSD2 (0.47) | NSD2MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL519774 | 0.77 | NSD2 (0.47) | NSD2MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL7195481 | 0.77 | CA2 (0.57) | MEN1KMT2AMAPTSMN1; SMN2KDM4E | |
| SCHEMBL2893576 | 0.76 | NSD2 (0.50) | NSD2MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL30565211 | 0.76 | CA1 (0.52) | NSD2MEN1KMT2AMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110105324-A1 | Herbicidal Compounds Based on N-Azinyl-N-Phenylsulfonylureas | BAYER CROPSCIENCE AG (DE) | 2011-05-05 | — | — | US | disclosed |
| US-20110105324-A1 | Herbicidal Compounds Based on N-Azinyl-N-Phenylsulfonylureas | BAYER CROPSCIENCE AG (DE) | 2011-05-05 | — | — | US | disclosed |
| EP-2278881-A1 | HERBICIDAL COMPOUNDS BASED ON N-AZINYL-N'-PHENYLSULFONYLUREAS | Bayer CropScience AG (DE) | 2011-02-02 | — | — | EP | disclosed |
| WO-2009127378-A1 | HERBICIDAL COMPOUNDS BASED ON N-AZINYL-N'-PHENYLSULFONYLUREAS | BAYER CROPSCIENCE AG (DE) | 2009-10-22 | — | — | WO | disclosed |
| WO-2009127378-A1 | HERBICIDAL COMPOUNDS BASED ON N-AZINYL-N'-PHENYLSULFONYLUREAS | BAYER CROPSCIENCE AG (DE) | 2009-10-22 | — | — | WO | disclosed |
| EP-2110019-A1 | Herbicidal compounds based on N-Azinyl-N'-phenylsulfonylureas | Bayer CropScience AG (DE) | 2009-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105324-A1 | Herbicidal Compounds Based on N-Azinyl-N-Phenylsulfonylureas | DDT, AZI2, PFAS | NSD2 379/4885MEN1 4118/4885KMT2A 204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.